Title of article - Compensation for Managing Population Health.
Abstract
Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes while HSV-1 is responsible for orolabial and facial lesions. In immunocompromised individuals, like HIV patients, impaired immunity leads to more frequent symptomatic and asymptomatic HSV infection. Fifty-two blood samples from HIV patients with clinically diagnosed HSV infection were taken as cases, while 45 blood samples each from HIV-infected (HIV control) and noninfected patients without any herpetic lesion (non-HIV control) were taken as control. Serum was tested for IgM and IgG antibodies of both HSV-1 and HSV-2 by ELISA. The seroprevalence was compared among the three groups of study population, considering the demographic and socioeconomic parameters. The HSV-2 IgM was significantly higher (p < 0.005) in the HIV patient group (34.6%) than the HIV control (2.2%) and non-HIV control (2.2%) groups, whereas HSV-2 IgG seroprevalence was higher in both HIV patient (61.5%) and HIV control (57.8%) groups than the non-HIV control group (17.8%). The prevalence of HSV-2 was significantly higher in persons with multiple partners and in the reproductive age group. The overall seroprevalence of HSV-1 IgM was too low (<5%), whereas it was too high (about 90%) with HSV-1 IgG in all three study groups.
CLICK HERE for Full article Click button above to go to original article link with complete article details for Compensation for Managing Population Health.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
Editor-in-Chief, American Health & Drug Benefits ; Founding Dean, Jefferson School of Population Health, Philadelphia, PA.
Details of Journal for Compensation for Managing Population Health.
Journal Title - American health & drug benefits
ISSN - 1942-2962
Volume - 8
Issue - 6
Publish date - 2015-Sep
Language - eng
Country - United States
No comments:
Post a Comment